Scientists identify protein markers related to the most common form of leukaemia
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. New research…
Browsing: Leukaemia
Ibrutinib effective treatment for difficult to treat forms of hairy cell leukaemia
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell…
Scientists provide new insight on how to stop transcription of cancer cells
Scientists from the UCLA Jonsson Comprehensive Cancer Center, USA, have identified a key protein, transcription…
Ficlatuzumab plus chemotherapy shows promise for the treatment of patients with relapsed/refractory acute myeloid leukaemia
The investigational therapeutic ficlatuzumab in combination with chemotherapy showed signs of clinical efficacy in patients…
Can leukaemia in children with Down syndrome be prevented?
For the first time, Princess Margaret researchers (Canada) have mapped out where and how leukaemia…
Unraveling the mechanisms that create the individualised metabolism in leukaemia
A research collaboration based in Kumamoto University (Japan) has shown that lysine-specific demethylase 1 (LSD1),…
European Commission approval for azacitidine tablets as frontline oral maintenance therapy for adults with acute myeloid leukaemia
Bristol Myers Squibb announced that the European Commission (EC) has granted full marketing authorisation for…
Researchers explore link between inflammation and leukaemia
Two recent collaborative publications by Colorado University Cancer Center (USA) members provide insights into how…
Novel risk score for predicting blood cancer relapse
Leukaemia is a group of blood cancers that affects thousands of people worldwide. However, with…
Study identifies risk for some childhood cancer patients developing secondary leukaemia
Scientists from the Wellcome Sanger Institute and the University of Cambridge, UK, found that in…